2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Neoadjuvant Chemotherapy: new trials by email Literature Review of Neoadjuvant Chemotherapy trials Research Report on Neoadjuvant Chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma dose dense MVAC with pegylated GCSF - Muscle Invasive Bladder Cancer, Urothelial Carcinoma | Phase 2 | Terminated | Pusan National University Yangsan Hospital | 24 | 2019-05-01 | 2026-09-18 |
| Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer S1,, Paclitaxel-albumin - Pancreatic Cancer, Neoadjuvant Chemotherapy | Phase 2 | Terminated | Zhejiang Provincial People's Hospital | 40 | 2017-11-20 | 2021-01-08 |
Carcinoma, Transitional Cell (1) · Pancreatic Neoplasms (1)
Neoplasms (2) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Pancreatic Diseases (1)
S 1 (combination) (1) · gimeracil (1)
Pusan National University Yangsan Hospital (1) · Zhejiang Provincial People's Hospital (1)
China (1) · South Korea (1)
PMID 11352955, PMID 11600601, PMID 12586807, PMID 12771730, PMID 12944571, PMID 15939524, PMID 16034041, PMID 21502557, PMID 24373477, PMID 24472710, PMID 24669010, PMID 24821881, PMID 24821883, PMID 25257030, PMID 26205531, PMID 26421586, PMID 27053504, PMID 28625005, PMID 29329894